Oliver Chen, TD Cowen senior retail analyst, joins 'Money Movers' to discuss Wall Street's reaction to Walmart's quarterly ...

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

Rion Aesthetics, a company at the forefront of exosome technology in the aesthetics industry, today announced its ...

TD Cowen analyst Dan Brennan raised the firm’s price target on Guardant Health (GH) to $56 from $42 and keeps a Buy rating on the shares. The firm said results were inline with the preannouncement ...

TD Cowen lowered the firm’s price target on Freshpet (FRPT) to $141 from $174 and keeps a Buy rating on the shares post the Q4 report.

TD Cowen raised the firm’s price target on Travere Therapeutics (TVTX) to $30 from $24 and keeps a Buy rating on the shares. The firm said Q4 ...

CNBC’s Eamon Javers and TD Cowen’s Roman Schweizer, join 'The Exchange' to discuss Trump's comments on halving defense ...

Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation ...

Investors and the general public are invited to listen to a live webcast of the presentation through the "Investors" section ...

Charles Schwab (NYSE:SCHW – Get Free Report) was upgraded by equities researchers at TD Cowen from a “hold” rating to a “buy” ...

today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat ...

TriNet Group (NYSE:TNET – Get Free Report) was downgraded by equities research analysts at TD Cowen from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, Ratings ...